Medtronic Total Assets Growth & History (MDT)
Medtronic's total assets was $93.03B for fiscal 2026.
View full Medtronic company overviewMedtronic annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $93.03B | $1.35B | +1.47% |
| 2025 | 2025-04-25 | $91.68B | $1.70B | +1.89% |
| 2024 | 2024-04-26 | $89.98B | −$967.0M | −1.06% |
| 2023 | 2023-04-28 | $90.95B | −$33.0M | −0.04% |
| 2022 | 2022-04-29 | $90.98B | −$2.10B | −2.26% |
| 2021 | 2021-04-30 | $93.08B | $2.39B | +2.64% |
| 2020 | 2020-04-24 | $90.69B | $995.0M | +1.11% |
| 2019 | 2019-04-26 | $89.69B | −$1.70B | −1.86% |
| 2018 | 2018-04-27 | $91.39B | −$8.46B | −8.48% |
| 2017 | 2017-04-28 | $99.86B | $213.0M | +0.21% |
| 2016 | 2016-04-29 | $99.64B | −$7.04B | −6.60% |
| 2015 | 2015-04-24 | $106.69B | $68.74B | +181.17% |
| 2014 | 2014-04-25 | $37.94B | — | — |
Medtronic quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $93.31B | $2.33B | +2.57% |
| Q4 2026 | 2026-04-24 | $93.03B | $1.35B | +1.47% |
| Q3 2026 | 2026-01-31 | $91.48B | $1.51B | +1.68% |
| Q3 2026 | 2026-01-23 | $91.48B | $1.51B | +1.68% |
| Q2 2026 | 2025-10-24 | $91.35B | $1.30B | +1.45% |
| Q1 2026 | 2025-07-25 | $90.97B | $1.22B | +1.36% |
| Q4 2025 | 2025-04-25 | $91.68B | $1.70B | +1.89% |
| Q3 2025 | 2025-01-24 | $89.97B | −$863.0M | −0.95% |
| Q2 2025 | 2024-10-25 | $90.04B | −$45.0M | −0.05% |
| Q1 2025 | 2024-07-26 | $89.75B | −$1.03B | −1.13% |
| Q4 2024 | 2024-04-26 | $89.98B | −$967.0M | −1.06% |
| Q3 2024 | 2024-01-26 | $90.84B | −$3.30B | −3.50% |
| Q2 2024 | 2023-10-27 | $90.09B | −$3.15B | −3.38% |
| Q1 2024 | 2023-07-28 | $90.78B | $862.0M | +0.96% |
| Q4 2023 | 2023-04-28 | $90.95B | −$33.0M | −0.04% |
| Q3 2023 | 2023-01-27 | $94.13B | $2.33B | +2.54% |
| Q2 2023 | 2022-10-28 | $93.24B | $1.49B | +1.62% |
| Q1 2023 | 2022-07-29 | $89.91B | −$1.89B | −2.06% |
| Q4 2022 | 2022-04-29 | $90.98B | −$2.10B | −2.26% |
| Q3 2022 | 2022-01-28 | $91.80B | −$5.47B | −5.62% |
| Q2 2022 | 2021-10-29 | $91.76B | −$4.13B | −4.31% |
| Q1 2022 | 2021-07-30 | $91.80B | −$2.10B | −2.24% |
| Q4 2021 | 2021-04-30 | $93.08B | $2.39B | +2.64% |
| Q3 2021 | 2021-01-29 | $97.27B | $4.45B | +4.79% |
| Q2 2021 | 2020-10-30 | $95.89B | $4.83B | +5.31% |
| Q1 2021 | 2020-07-31 | $93.91B | $2.64B | +2.89% |
| Q4 2020 | 2020-04-24 | $90.69B | $995.0M | +1.11% |
| Q3 2020 | 2020-01-24 | $92.82B | $4.09B | +4.61% |
| Q2 2020 | 2019-10-25 | $91.05B | $2.90B | +3.29% |
| Q1 2020 | 2019-07-26 | $91.27B | $1.55B | +1.72% |
| Q4 2019 | 2019-04-26 | $89.69B | −$1.70B | −1.86% |
| Q3 2019 | 2019-01-25 | $88.73B | −$7.07B | −7.38% |
| Q2 2019 | 2018-10-26 | $88.15B | −$6.31B | −6.68% |
| Q1 2019 | 2018-07-27 | $89.72B | −$10.53B | −10.50% |
| Q4 2018 | 2018-04-27 | $91.39B | −$8.46B | −8.48% |
| Q3 2018 | 2018-01-26 | $95.80B | −$1.78B | −1.82% |
| Q2 2018 | 2017-10-27 | $94.46B | −$3.95B | −4.01% |
| Q1 2018 | 2017-07-28 | $100.25B | $1.65B | +1.67% |
| Q4 2017 | 2017-04-28 | $99.86B | $213.0M | +0.21% |
| Q3 2017 | 2017-01-27 | $97.58B | −$5.13B | −4.99% |
| Q2 2017 | 2016-10-28 | $98.41B | −$6.54B | −6.23% |
| Q1 2017 | 2016-07-29 | $98.60B | −$6.03B | −5.76% |
| Q4 2016 | 2016-04-29 | $99.64B | −$7.04B | −6.60% |
| Q3 2016 | 2016-01-29 | $102.71B | — | — |
| Q2 2016 | 2015-10-30 | $104.94B | — | — |
| Q1 2016 | 2015-07-31 | $104.63B | — | — |
| Q4 2015 | 2015-04-24 | $106.69B | $68.74B | +181.17% |
| Q4 2014 | 2014-04-25 | $37.94B | — | — |
Medtronic total assets trends
Over the last five fiscal years, Medtronic's total assets decreased from $93.08B to $93.03B, a change of −$55.0M. The latest reported quarter, Q1 2027, shows $93.31B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic gains cardiac-software clearances across two ablation platforms
Medtronic ($MDT) obtained FDA clearance and a European CE mark for its latest Affera Prism-2 cardiac mapping software, alongside a CE mark for the PulseSelect ProxBox adapter and Proximity Indicator software. The Affera upgrade adds tools f ...
Medtronic’s GI Genius system shows gains in large clinical-practice study
Cosmo reported new results for GI Genius, the AI-assisted endoscopy system it develops and Medtronic ($MDT) commercializes. The cluster-randomized quality-improvement study covered more than 334,000 colonoscopies across 139 US Veterans Heal ...
Medtronic wins FDA clearance for LigaSure instrument on Hugo robot
Medtronic ($MDT) received FDA clearance for the LigaSure RAS Maryland jaw instrument for its Hugo robotic-assisted surgery system. The instrument brings the company’s vessel-sealing technology to the robotic platform and is designed to seal ...
Medtronic launches MiniMed share-exchange offer
Medtronic ($MDT) launched an exchange offer to split off at least 80.1% of MiniMed ($MMED), its former diabetes business. Investors can voluntarily exchange Medtronic shares for MiniMed stock at a 7% discount, subject to a cap of 4.5939 Min ...
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...